lactic acid has been researched along with sesquiterpenes in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (8.70) | 18.7374 |
1990's | 3 (13.04) | 18.2507 |
2000's | 13 (56.52) | 29.6817 |
2010's | 5 (21.74) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bayorh, MA; Faden, AI; Feuerstein, G; Goldstein, DS; Lux, WE; Ramwell, PW; Zerbe, RL | 1 |
Baer, W; Chmiel, J; Gnojkowski, J; Klimek, D | 1 |
Kuge, Y; Misaki, M; Ogawa, Y; Okada, H; Saito, K; Toguchi, H; Yanai, S | 1 |
Chamblee, BB; Deck, LM; Hernandez, VM; Hunsaker, LA; Makler, MT; Malone, RR; Piper, RC; Royer, RE; Torres, JE; Vander Jagt, DL | 1 |
Feng, Z; Guo, HF; Jiao, PY; Mei, JY; Xiao, SH; Yao, MY; You, JQ | 1 |
Agbenyega, T; Angus, BJ; Baffoe-Bonnie, B; Bedu-Addo, G; Guyton, T; Krishna, S; Stacpoole, PW | 1 |
Fujiie, S; Kaetsu, I; Kakinoki, S; Kato, M; Kuroda, D; Nakayama, M; Ohyanagi, H; Uchida, K; Yasuda, C; Yukutake, K | 1 |
Fu, X; Gao, Y; Ping, Q | 2 |
Chu, DF; Li, YX; Liu, K; Liu, WH; Song, JL | 1 |
Fu, XD; Gao, YL; Ping, QN; Ren, T | 1 |
Chen, D; Ding, P; Gao, P; Wei, J; Xu, H; Yuan, Z | 1 |
Chu, DF; Fu, XQ; Li, YX; Liu, K; Liu, WH | 1 |
Chen, D; Ding, P; Gao, P; Gao, Q; Sun, J; Xu, H | 1 |
Fu, XD; Gao, YL; Ping, QN | 1 |
Fu, F; Liu, J; Liu, K; Ma, H; Wang, C; Zhang, T | 1 |
Chu, D; Li, Y; Li, Z; Liu, W; Tian, J | 1 |
Feng, S; Huang, D; Lee, YK; Saw, CL | 1 |
Fu, F; He, J; Li, Y; Liu, W; Sun, K; Tian, J; Ye, L; Yu, P; Yu, X | 1 |
Di, W; Duan, Y; Liu, P; Liu, X; Qiu, L; Wang, Q; Wang, W; Wang, X; Wang, Y; Yin, X; Zhou, J | 1 |
Akbarzadeh, A; Barkhordari, A; Ghasemali, S; Kordi, S; Rahmati, YM; Tozihi, M; Zarghami, N | 1 |
Hua, H; Jiang, Y; Meng, Q; Mu, H; Sun, K; Wang, A; Wang, Y; Wu, Z | 1 |
Koyama, Y; Nishimura, I; Oguma, T; Shinohara, Y | 1 |
1 trial(s) available for lactic acid and sesquiterpenes
Article | Year |
---|---|
Glucose and lactate kinetics in children with severe malaria.
Topics: Acidosis, Lactic; Antimalarials; Artemisinins; Artesunate; Blood Glucose; Child; Child, Preschool; Dichloroacetic Acid; Female; Humans; Infant; Insulin; Kinetics; Lactic Acid; Malaria, Falciparum; Male; Quinine; Sesquiterpenes | 2000 |
22 other study(ies) available for lactic acid and sesquiterpenes
Article | Year |
---|---|
Cardiorespiratory, sympathetic and biochemical responses to T-2 toxin in the guinea pig and rat.
Topics: Animals; Arachidonic Acids; Arginine Vasopressin; Blood Gas Analysis; Blood Pressure; Cardiac Output; Catecholamines; Guinea Pigs; Heart Rate; Hematocrit; Hemodynamics; Hydrogen-Ion Concentration; Lactates; Lactic Acid; Male; Neurosecretory Systems; Rats; Rats, Inbred Strains; Respiration; Sesquiterpenes; Spinal Cord; Sympathetic Nervous System; T-2 Toxin; Vascular Resistance | 1985 |
The effect of sesquiterpene lactones, eupatoriopicrin and hydroxyisonobilin, on the glycolytic metabolism of human lymphocytes.
Topics: Antineoplastic Agents; DNA; Glyceraldehyde-3-Phosphate Dehydrogenases; Glycolysis; Humans; In Vitro Techniques; L-Lactate Dehydrogenase; Lactates; Lactic Acid; Lymphocytes; Sesquiterpenes | 1983 |
Antitumor effect of arterial administration of a medium-chain triglyceride solution of an angiogenesis inhibitor, TNP-470, in rabbits bearing VX-2 carcinoma.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Caprylates; Carcinoma; Chemistry, Pharmaceutical; Cyclohexanes; Decanoic Acids; Doxorubicin; Female; Injections, Intra-Arterial; Lactic Acid; Male; Mitomycin; Neoplasm Transplantation; Neoplasms, Experimental; Neovascularization, Pathologic; O-(Chloroacetylcarbamoyl)fumagillol; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rabbits; Sesquiterpenes; Solutions; Triglycerides | 1995 |
Selective inhibitors of human lactate dehydrogenases and lactate dehydrogenase from the malarial parasite Plasmodium falciparum.
Topics: Animals; Enzyme Inhibitors; Humans; Kinetics; L-Lactate Dehydrogenase; Lactic Acid; NAD; Oxidation-Reduction; Plasmodium falciparum; Pyruvic Acid; Sesquiterpenes | 1998 |
Effect of artemether on glyceraldehyde-3-phosphate dehydrogenase, phosphoglycerate kinase, and pyruvate kinase of Schistosoma japonicum harbored in mice.
Topics: Animals; Artemether; Artemisinins; Female; Glyceraldehyde-3-Phosphate Dehydrogenases; Lactic Acid; Male; Mice; Phosphoglycerate Kinase; Pyruvate Kinase; Schistosoma japonicum; Schistosomiasis japonica; Schistosomicides; Sesquiterpenes; Sex Factors | 1998 |
Preparation of poly-lactic acid microspheres containing the angiogenesis inhibitor TNP-470 with medium-chain triglyceride and the in vitro evaluation of release profiles.
Topics: Angiogenesis Inhibitors; Chemistry, Pharmaceutical; Cyclohexanes; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Drug Stability; Half-Life; Lactic Acid; Methylene Chloride; Microscopy, Electron, Scanning; Microspheres; O-(Chloroacetylcarbamoyl)fumagillol; Particle Size; Polyesters; Polymers; Sesquiterpenes; Time Factors; Triglycerides | 2003 |
Effects of formulation factors on encapsulation efficiency and release behaviour in vitro of huperzine A-PLGA microspheres.
Topics: Alkaloids; Biocompatible Materials; Cholinesterase Inhibitors; Drug Compounding; Hot Temperature; Lactic Acid; Microscopy, Electron, Scanning; Microspheres; Molecular Weight; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Sesquiterpenes; Solvents | 2005 |
Preparation and in vitro and in vivo release studies of Huperzine A loaded microspheres for the treatment of Alzheimer's disease.
Topics: Alkaloids; Alzheimer Disease; Animals; Cholinesterase Inhibitors; Desiccation; Dogs; Drug Compounding; Drug Stability; Lactic Acid; Microscopy, Electron, Scanning; Microspheres; Neuroprotective Agents; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Sesquiterpenes; Solubility; Water | 2005 |
Preparation and in vivo evaluation of huperzine A-loaded PLGA microspheres.
Topics: Alkaloids; Animals; Cholinesterase Inhibitors; Lactic Acid; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rats; Rats, Sprague-Dawley; Sesquiterpenes | 2005 |
In vitro and in vivo characterization of huperzine a loaded microspheres made from end-group uncapped poly(d,l-lactide acid) and poly(d,l-lactide-co-glycolide acid).
Topics: Alkaloids; Animals; Drug Compounding; Injections, Subcutaneous; Lactic Acid; Male; Microscopy, Electron, Scanning; Microspheres; Neuroprotective Agents; Particle Size; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rats; Rats, Wistar; Sesquiterpenes; Viscosity | 2006 |
Effects of formulation factors on encapsulation efficiency and release behaviour in vitro of huperzine A-PLGA microspheres.
Topics: Alkaloids; Alzheimer Disease; Delayed-Action Preparations; Drug Compounding; Humans; Lactic Acid; Microscopy, Confocal; Microscopy, Electron, Scanning; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Sesquiterpenes | 2005 |
Pharmacokinetics and in vitro and in vivo correlation of huperzine A loaded poly(lactic-co-glycolic acid) microspheres in dogs.
Topics: Alkaloids; Animals; Area Under Curve; Biological Availability; Cholinesterase Inhibitors; Chromatography, Liquid; Dogs; Drug Compounding; Female; Injections, Intramuscular; Injections, Subcutaneous; Lactic Acid; Male; Mass Spectrometry; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Sesquiterpenes | 2006 |
Controlled release of huperzine A from biodegradable microspheres: In vitro and in vivo studies.
Topics: Acetylcholinesterase; Alkaloids; Alzheimer Disease; Animals; Calorimetry, Differential Scanning; Cerebral Cortex; Cholinesterase Inhibitors; Delayed-Action Preparations; Drug Stability; Lactic Acid; Male; Microscopy, Electron, Scanning; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rats; Rats, Wistar; Sesquiterpenes | 2007 |
[Effect of preparation technique on in vitro release mechanism of huperzine A microspheres].
Topics: Alkaloids; Cholinesterase Inhibitors; Drug Compounding; Lactic Acid; Microscopy, Confocal; Microscopy, Electron, Scanning; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Sesquiterpenes | 2006 |
Prolonged effects of poly(lactic-co-glycolic acid) microsphere-containing huperzine A on mouse memory dysfunction induced by scopolamine.
Topics: Acetylcholinesterase; Alkaloids; Animals; Avoidance Learning; Cerebral Cortex; Delayed-Action Preparations; Drug Carriers; Lactic Acid; Male; Memory Disorders; Mice; Microspheres; Muscarinic Antagonists; Neuroprotective Agents; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Reaction Time; Scopolamine; Sesquiterpenes; Spectrophotometry | 2007 |
Poly(lactic-co-glycolic acid) microspheres for the controlled release of huperzine A: in vitro and in vivo studies and the application in the treatment of the impaired memory of mice.
Topics: Alkaloids; Animals; Cholinesterase Inhibitors; Lactic Acid; Memory Disorders; Mice; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Sesquiterpenes | 2007 |
Novel process of fermenting black soybean [Glycine max (L.) Merrill] yogurt with dramatically reduced flatulence-causing oligosaccharides but enriched soy phytoalexins.
Topics: Bacteria; Fermentation; Flatulence; Food Handling; Glycine max; Lactic Acid; Oligosaccharides; Phytoalexins; Pterocarpans; Rhizopus; Sesquiterpenes; Terpenes; Yogurt | 2008 |
Preparation and in vitro and in vivo evaluation of HupA PLGA microsphere.
Topics: Acetylcholinesterase; Administration, Oral; Alkaloids; Amyloid beta-Peptides; Animals; Behavior, Animal; Brain; Chemistry, Pharmaceutical; Cholinesterase Inhibitors; Cognition; Cognition Disorders; Delayed-Action Preparations; Disease Models, Animal; Drug Carriers; GPI-Linked Proteins; Injections, Intramuscular; Lactic Acid; Male; Memory; Microspheres; Particle Size; Peptide Fragments; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Technology, Pharmaceutical | 2013 |
Specific cell targeting with APRPG conjugated PEG-PLGA nanoparticles for treating ovarian cancer.
Topics: Angiogenesis Inhibitors; Animals; Cyclohexanes; Drug Delivery Systems; Female; Human Umbilical Vein Endothelial Cells; Humans; Lactic Acid; Mice; Nanoparticles; Neovascularization, Pathologic; O-(Chloroacetylcarbamoyl)fumagillol; Oligopeptides; Ovarian Neoplasms; Ovary; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Sesquiterpenes | 2014 |
A comparison of the inhibitory effect of nano-encapsulated helenalin and free helenalin on telomerase gene expression in the breast cancer cell line, by real-time PCR.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Drug Carriers; Gene Expression Regulation, Neoplastic; Humans; Lactic Acid; Nanocapsules; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Real-Time Polymerase Chain Reaction; Safety; Sesquiterpenes; Sesquiterpenes, Guaiane; Telomerase | 2016 |
Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease.
Topics: Administration, Intranasal; Alkaloids; Alzheimer Disease; Animals; Brain; Chitosan; Drug Carriers; Drug Delivery Systems; Humans; Lactic Acid; Lactoferrin; Mice; Nanoparticles; Neuroprotective Agents; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Sesquiterpenes; Tissue Distribution | 2018 |
Survival strategy of the salt-tolerant lactic acid bacterium, Tetragenococcus halophilus, to counteract koji mold, Aspergillus oryzae, in soy sauce brewing.
Topics: Amino Acid Sequence; Aspergillus oryzae; Enzyme Inhibitors; Fermentation; Food Industry; Glyceraldehyde-3-Phosphate Dehydrogenases; Lactic Acid; Lactobacillales; Microbial Sensitivity Tests; Salt Tolerance; Sequence Homology, Amino Acid; Sesquiterpenes; Soy Foods | 2018 |